SIGI
TAK icon

Susquehanna International Group (Ireland)’s Takeda Pharmaceutical TAK Stock Holding History

Susquehanna International Group (Ireland)’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-95,546
Closed -$1.61M – 99
2021
Q2 		$1.61M Buy
+95,546
New +$1.63M 0.55% 21

Other funds holding TAK

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Susquehanna International Group (Ireland)'s TAK Position: Q3 2021 in Review

Susquehanna International Group (Ireland) sold out of Takeda Pharmaceutical (TAK) in Q3 2021, closing a stake of 95,546 shares — an estimated $1.61M sold.

Susquehanna International Group (Ireland) first reported a position in TAK in Q2 2021 and held it in 1 quarter. The position peaked at $1.61M in Q2 2021. 293 funds tracked by Wall St. Rank hold TAK as of Q3 2021.

  • Susquehanna International Group (Ireland) reported no remaining Takeda Pharmaceutical position as of Q3 2021 after selling out during the quarter.
  • Susquehanna International Group (Ireland) sold 95,546 Takeda Pharmaceutical shares in Q3 2021, an estimated $1.61M.
  • Susquehanna International Group (Ireland) first reported a position in Takeda Pharmaceutical in Q2 2021 and held it in 1 quarter.
  • Susquehanna International Group (Ireland)'s Takeda Pharmaceutical position peaked at $1.61M in Q2 2021.
  • 293 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2021.

Based on Susquehanna International Group (Ireland)'s 13F filing for Q3 2021, filed 15 Nov 2021.